LeMaitre Vascular Inc (LMAT)
LeMaitre Vascular provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease, end-stage renal disease, and to a lesser extent cardiovascular disease. Co.'s portfolio of devices consists of products that are used in arteries and veins. Co.'s product offerings include a suite of biologic products, which include the XenoSure patch (bovine pericardium), CardioCel and VascuCel patches (bovine pericardium), ProCol graft (bovine mesenteric vein), Artegraft (bovine carotid artery), Omniflow II biosynthetic graft (ovine tissue and synthetic mesh) and the RestoreFlow Allograft cryopreserved graft (human cadaver tissue).
LMAT SEC Filing Email Alerts Service
| Company Name: |
LeMaitre Vascular Inc |
| Website: |
www.lemaitre.com |
| Sector: |
Medical Instruments & Supplies |
| Number of ETFs Holding LMAT: |
48 |
| Total Market Value Held by ETFs: |
$266.24M |
| Total Market Capitalization: |
$1.43B |
| % of Market Cap. Held by ETFs: |
18.59% |
|
|
April 18, 2024 • 1:20 PM Eastern
Buy (3.14 out of 4)
100th percentile
|
|
Free LMAT Email Alerts:
